Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Retained Earnings (2020 - 2023)

Terns Pharmaceuticals (TERN) has disclosed Retained Earnings for 4 consecutive years, with -$836000.0 as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Retained Earnings rose 37.98% year-over-year to -$836000.0, compared with a TTM value of -$836000.0 through Sep 2023, up 37.98%, and an annual FY2022 reading of -$822000.0, up 99.55% over the prior year.
  • Retained Earnings was -$836000.0 for Q3 2023 at Terns Pharmaceuticals, up from -$281.8 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$124000.0 in Q4 2020 and bottomed at -$281.8 million in Q2 2023.
  • Average Retained Earnings over 4 years is -$121.7 million, with a median of -$161.9 million recorded in 2021.
  • The sharpest move saw Retained Earnings tumbled 146733.06% in 2021, then skyrocketed 99.55% in 2022.
  • Year by year, Retained Earnings stood at -$124000.0 in 2020, then crashed by 146733.06% to -$182.1 million in 2021, then surged by 99.55% to -$822000.0 in 2022, then decreased by 1.7% to -$836000.0 in 2023.
  • Business Quant data shows Retained Earnings for TERN at -$836000.0 in Q3 2023, -$281.8 million in Q2 2023, and -$263.9 million in Q1 2023.